Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.73B
Close$
$-1.87
117% downside
Current Fair Value
117% downsideOvervalued by 117% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.73 Billion |
|---|---|
| Enterprise Value | $7.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 0.02 |
| Outstanding Shares | 611,689,055 |
Return
| Return on Equity | -5.78% |
|---|---|
| Return on Assets | -3.38% |
| Return on Invested Capital | -4.59% |
Valuation & Multiples
| P/E Ratio | -122.77 |
|---|---|
| PEG | -5.63 |
| Price to Sales | 11.0 |
| Price to Book Ratio | 2.75 |
| Enterprise Value to Revenue | 6.15 |
| Enterprise Value to EBIT | -51.16 |
| Enterprise Value to Net Income | -48 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Wanbangde Pharmaceutical Holding Group Co., Ltd.
1,348 employees
CEO: Shouming Zhao Established in 1985 and headquartered in Taizhou, China, Wanbangde Pharmaceutical Holding Group Co., Ltd. primarily focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines, active pharmaceut...